Delivering email at scale is a technically challenging endeavour, and getting it wrong could shut down the entire email communication channel. In fact, this…
Accra-based healthtech startup Redbird has secured $1.5-million in a Seed Round of investment with participation from Johnson & Johnson Foundation and Newtown Partners via the Imperial Venture Fund.
Redbird has secured $1.5-million in a Seed Round of investment
According to reports by the healthtech startup, the funding will be used to expand Redbird’s business model, operations and to enter new markets.
Patrick Beattie, co-founder, and CEO of Redbird comments on the investment received and working alongside the investors.
“We’re thrilled to work with Johnson & Johnson Impact Ventures and Newtown Partners. Newtown and Imperial’s expertise in African supply chains, coupled with Johnson & Johnson’s long-standing commitment to improving care for the most vulnerable populations through technology, create strong support for our vision of revolutionizing health monitoring,” Beattie said.
Founded in 2018, the innovative African tech healthtech startup enables patients in the region to easily manage their health through five-minute medical tests available at community pharmacies. Merging technology with health, the startup’s app enables patients to access their health records digitally
The decentralised business model ensures that healthcare is available to all individuals in the region. Redbird offers access to medical testing for chronic diseases. This system enables patients in Ghana to receive an accurate diagnosis and how to manage and track their possible chronic illnesses such as diabetes.
According to reports, Redbird is a partner with 340 pharmacies in Ghana where individuals can access medical testing and register for the platform.
Currently, there are 10 different rapid tests available for individuals. The results are kept private and saved to individuals’ personal Redbird health records on the app. Working hand-in-hand with medical professionals, doctors are provided the results, with the consent of users, to provide a complete picture of a patient’s medical health history.
Llew Claasen, Managing Partner of Newtown Partners comments on the investment made into the healthtech startup.
“We’re excited about Redbird’s decentralised business model that enables rapid diagnostic testing at the point of primary care in local community pharmacies. Redbird’s digital health record platform has the potential to drive significant value to the broader healthcare value chain and is a vital step toward improving healthcare outcomes in Africa. We look forward to supporting the team as they prove out their business model and scale across the African continent.”
Featured image: Redbird team, (Supplied)